SYRE
Spyre Therapeutics, Inc.Company with tickers: SYRE
CIK
1636282
CUSIP
00773J202
Shares Outstanding
86,841,253
13F Activity (30d)
153 filings
151 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-06-03 | Sloan Sheldon |
Chief Medical Officer | Sell | 8,333 |
| 2026-06-03 | Sloan Sheldon |
Chief Medical Officer | Convert | 8,333 |
| 2026-06-03 | Sloan Sheldon |
Chief Medical Officer | Convert | 8,333 |
| 2026-06-01 | Burrows Scott L |
Chief Financial Officer | Convert | 7,500 |
| 2026-06-01 | Burrows Scott L |
Chief Financial Officer | Sell | 1,801 |
| 2026-06-01 | Turtle Cameron |
Director | Sell | 8,149 |
| 2026-06-01 | Turtle Cameron |
Director | Sell | 3,557 |
| 2026-06-01 | Turtle Cameron |
Director | Sell | 3,294 |
| 2026-06-01 | Burrows Scott L |
Chief Financial Officer | Convert | 7,500 |
| 2026-06-01 | Burrows Scott L |
Chief Financial Officer | Sell | 2,599 |
| 2026-06-01 | Burrows Scott L |
Chief Financial Officer | Sell | 3,100 |
| 2026-05-27 | Albers Jeffrey W. |
Director | Award | 8,026 |
| 2026-05-27 | McKenna Mark C. |
Director | Award | 8,026 |
| 2026-05-27 | Fairmount Funds Management LLC |
Director | Award | 8,026 |
| 2026-05-27 | HENDERSON MICHAEL THOMAS |
Chief Business Officer | Award | 8,026 |
| 2026-05-27 | Milligan Sandra |
Interim CEO & President | Award | 8,026 |
| 2026-05-27 | Stelzer Laurie |
Director | Award | 8,026 |
| 2026-05-08 | HENDERSON MICHAEL THOMAS |
Chief Business Officer | Sell | 2,404 |
| 2026-05-08 | HENDERSON MICHAEL THOMAS |
Chief Business Officer | Sell | 19,269 |
| 2026-05-08 | HENDERSON MICHAEL THOMAS |
Chief Business Officer | Sell | 24,814 |
| 2026-05-08 | HENDERSON MICHAEL THOMAS |
Chief Business Officer | Sell | 33,513 |
| 2026-05-01 | Sloan Sheldon |
Chief Medical Officer | Sell | 19,656 |
| 2026-05-01 | Turtle Cameron |
Director | Sell | 300 |
| 2026-05-01 | Sloan Sheldon |
Chief Medical Officer | Sell | 12,777 |
| 2026-05-01 | Burrows Scott L |
Chief Financial Officer | Sell | 12,500 |
| 2026-05-01 | Sloan Sheldon |
Chief Medical Officer | Sell | 5,059 |
| 2026-05-01 | Turtle Cameron |
Director | Sell | 3,600 |
| 2026-05-01 | Sloan Sheldon |
Chief Medical Officer | Sell | 400 |
| 2026-05-01 | Sloan Sheldon |
Chief Medical Officer | Convert | 78,333 |
| 2026-05-01 | Burrows Scott L |
Chief Financial Officer | Convert | 12,500 |
| 2026-05-01 | Sloan Sheldon |
Chief Medical Officer | Sell | 10,358 |
| 2026-05-01 | Burrows Scott L |
Chief Financial Officer | Convert | 12,500 |
| 2026-05-01 | Sloan Sheldon |
Chief Medical Officer | Sell | 8,777 |
| 2026-05-01 | Turtle Cameron |
Director | Sell | 1,000 |
| 2026-05-01 | Sloan Sheldon |
Chief Medical Officer | Sell | 21,306 |
| 2026-05-01 | Turtle Cameron |
Director | Sell | 3,100 |
| 2026-05-01 | Turtle Cameron |
Director | Sell | 1,700 |
| 2026-05-01 | Sloan Sheldon |
Chief Medical Officer | Convert | 78,333 |
| 2026-05-01 | Turtle Cameron |
Director | Sell | 5,300 |
| 2026-04-01 | Burrows Scott L |
Chief Financial Officer | Sell | 1,300 |
| 2026-04-01 | Burrows Scott L |
Chief Financial Officer | Convert | 7,500 |
| 2026-04-01 | Sloan Sheldon |
Chief Medical Officer | Sell | 7,958 |
| 2026-04-01 | Turtle Cameron |
Director | Sell | 12,344 |
| 2026-04-01 | Sloan Sheldon |
Chief Medical Officer | Convert | 7,958 |
| 2026-04-01 | Turtle Cameron |
Director | Sell | 2,656 |
| 2026-04-01 | Burrows Scott L |
Chief Financial Officer | Convert | 7,500 |
| 2026-04-01 | Sloan Sheldon |
Chief Medical Officer | Convert | 7,958 |
| 2026-04-01 | Burrows Scott L |
Chief Financial Officer | Sell | 6,200 |
| 2026-03-03 | Burrows Scott L |
Chief Financial Officer | Sell | 2,300 |
| 2026-03-03 | Burrows Scott L |
Chief Financial Officer | Convert | 2,500 |
Showing 1–50 of 242 transactions